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Lithium was one of the first effective drugs to be intro-
duced to psychotherapeutics, and it remains an impor-
tant treatment both for mania and for the prophylaxis
of bipolar disorder. Its action in preventing recurrences
appears greater against mania than against depression.
A major trend in recent years has been the recognition
that antipsychotic drugs are useful not only in mania
and hypomania, but in preventing both mania and
depression in patients with bipolar I disorder. The antie-
pileptic agent lamotrigine is useful in preventing depres-
sion and to a lesser extent in preventing mania in
bipolar I disorder and in bipolar II rapid cycling. The
place of valproate or carbamazepine in long-term treat-
ment has not been firmly established. The effectiveness
of lithium is limited by side effects and poor compli-
ance. There is growing evidence that certain antipsycho-
tic agents are associated with better compliance and
greater effectiveness than lithium, although their meta-
bolic and endocrine side effects can be problematic.
Recent Guidelines recognise the role of antipsychotics in
the long-term management of bipolar disorder, along-
side lithium, lamotrigine and sometimes antidepressants.
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